Zodiac-JRD-MKJ Secures BSE Approval for Rs 40 Crore Capital Raise

BSE In-principle Approval Received: November 3, 2026
Proposed Capital Infusion: Up to Rs 40 Crore

Reader Takeaway: BSE approval clears the path for the board to finalize rights issue terms this week.

What just happened

Zodiac-JRD-MKJ Ltd has received in-principle approval from BSE Limited for its plan to raise up to Rs 40 crore through a rights issue. This regulatory nod follows the board's initial proposal made on August 6, 2026. The approval is a critical hurdle, as the company had previously deferred meetings to finalize specific issue parameters while awaiting this exchange confirmation.

Why this matters

Existing shareholders now await the board meeting scheduled for November 4, 2026. During this session, the company will finalize the issue price, the rights entitlement ratio (the number of shares offered per existing holding), and the critical record date. These details will directly influence the financial commitment required from investors and their eligibility to participate in the capital raise.

Upcoming Board Meeting

The upcoming meeting is designed to transition the rights issue from a concept to an actionable offer. Beyond the price and ratio, the board will finalize the terms and conditions that govern the offer period and shareholder participation. Investors should watch for the official filing following the conclusion of this meeting.

What to track next

Watch for the post-meeting disclosure on November 4 or 5, 2026. Shareholders should specifically monitor the record date, as only those holding shares on this date will be eligible to exercise their rights to purchase the new equity.